Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
New Bio (920685) on March 27th, day-trading funds net bought 2,531.00 yuan
Securities Star news, as of the market close on March 27, 2026, New Zhi Biological (920685) closed at 12.18 yuan, up 1.42%, with a turnover rate of 0.72%, a trading volume of 3964.0 lots, and a transaction value of 4.8017 million yuan.
Regarding the capital flow data on March 27, there was no net inflow of main funds, with a net inflow of speculative funds of 250 yuan, accounting for 0.05% of the total transaction value, and a net outflow of retail funds of 230 yuan, also accounting for 0.05% of the total transaction value.
The Q3 2025 financial report of New Zhi Biological shows that in the first three quarters, the company’s main revenue was 114 million yuan, a year-on-year increase of 5.04%; the net profit attributable to shareholders was 20.7091 million yuan, a year-on-year decrease of 4.36%; the net profit excluding non-recurring gains and losses was 15.5308 million yuan, a year-on-year decrease of 1.23%; among them, in Q3 2025, the company’s single-quarter main revenue was 43.022 million yuan, a year-on-year increase of 2.87%; the single-quarter net profit attributable to shareholders was 8.8435 million yuan, a year-on-year increase of 2.92%; the single-quarter net profit excluding non-recurring gains and losses was 6.602 million yuan, a year-on-year decrease of 8.32%; the debt ratio was 11.69%, investment income was 1.6968 million yuan, financial expenses were -522,300 yuan, and the gross profit margin was 62.7%. New Zhi Biological (920685) main business: research, production, and sales of life science instruments.
Capital flow terminology explanation: refers to inferring the capital flow through price changes. When stock prices are rising, the transaction amount generated by active buy orders is the force driving the stock price up, and this portion of the transaction amount is defined as capital inflow. When stock prices are falling, the transaction amount generated by active sell orders is the force driving the stock price down, and this portion of the transaction amount is defined as capital outflow. The difference between the two on that day is the net force remaining after the two forces counteract each other, which drives the stock price up. The main fund flow, speculative fund flow, and retail fund flow are calculated based on the transaction amount of each individual trade.
Note: Main funds refer to large transactions, speculative funds refer to big transactions, and retail funds refer to medium and small transactions.
The above content is organized by Securities Star based on publicly available information and generated by AI algorithms (Internet Information Office record number 310104345710301240019), and does not constitute investment advice.